EFFICIENCY OF NANOPARTICLES FOR DELIVERY OF DRUGS BY INHALATION
AbstractThe reason for this assessment became the blessing of the use of nanoparticles in lung disease. Nanotechnology has a critical characteristic in inhalation. The dosage shape of pulmonary drug shipping reaches to without delay into a scientific cycle to obtain the impact of the drug. The nanoparticles have a nanosize that achieves the preferred healthy without inflicting infection as compared to standard dosage forms. Various dosage kinds of the pulmonary drug shipping device meet the necessities of this assessment, like metered-dose inhalers, dry powder inhalers, and nebulizers. This drug has a significant impact on the target site. They are used for all kinds of diseases, including asthma, lung cancer, tuberculosis, and various lung diseases. You should easily get a nanometer particle length in the right place. Due to the physiological properties of the lung, the lung is suitable as a target organ for non-invasive short-range and systemic delivery of drug, primarily for non-bioavailable proteins and water-insoluble capsules for conventional drug delivery. Recently, inhaled nanoparticles have been shown to produce healing effects and reduce side effects while administered via the lungs. The possibility of delivering nanoparticles to the Department of Respiratory Medicine, especially given the latest discoveries in nanomaterials in environmental epidemiology and toxicology. Therefore, the purpose of this look is that the performance of nanoparticles is an excellent approach to lung drug delivery devices.
Article Information
6
3857-3863
859 KB
323
English
IJPSR
Pooja Singh *, Bhavna, Kumar Praven, Devi Sarika and Bhardwaj Priyanka
Department of Pharmacy, DIT University Dehradun, Uttarakhand, India.
pooja.pharmacare@gmail.com
18 February 2022
26 April 2022
29 April 2022
10.13040/IJPSR.0975-8232.13(10).3857-63
01 October 2022